MoneyWorks4Me

Net sales declined -12.24%  to  Rs. 4189.62 million from Rs. 4774.14 millions.The company suffered a huge decline of -87.72% to Rs. 214.79  millions from Rs. 1748.77 millions  of corresponding previous quarter.A decline of 767.99 millions was observed in the OP in the quarter ended March 2026 from 2408.65 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 4189.62 4774.14 -12.24 14053.81 12995.89 8.14 14053.81 12995.89 8.14
Other Income 20.93 39.09 -46.46 150.08 176.82 -15.12 150.08 176.82 -15.12
PBIDT 767.99 2408.65 -68.12 2840.01 3869.57 -26.61 2840.01 3869.57 -26.61
Interest 222.52 323.94 -31.31 1205.76 1616.50 -25.41 1205.76 1616.50 -25.41
PBDT 562.17 2084.71 -73.03 1580.05 1130.57 39.76 1580.05 1130.57 39.76
Depreciation 347.38 335.94 3.41 1367.95 1345.12 1.70 1367.95 1345.12 1.70
PBT 214.79 1748.77 -87.72 212.10 -214.55 -198.86 212.10 -214.55 -198.86
TAX 0.00 0.00 0.00 0.00 -414.55 0.00 0.00 -414.55 0.00
Deferred Tax 0.00 0.00 0.00 0.00 -414.55 0.00 0.00 -414.55 0.00
PAT 214.79 1748.77 -87.72 212.10 200.00 6.05 212.10 200.00 6.05
Equity 114.62 114.43 0.17 114.62 114.43 0.17 114.62 114.43 0.17
PBIDTM(%) 18.33 50.45 -63.67 20.21 29.78 -32.13 20.21 29.78 -32.13
Peers
Company Name CMP
Sun Pharma. Inds. 1864.00
Dr. Reddys Labs. 1140.80
Cipla 1380.00
Lupin 2075.00
Zydus Lifesciences 1118.00
View more..